Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Medtronic
Fuji
Teva
Citi
Colorcon
Argus Health
Novartis
Healthtrust

Generated: January 21, 2018

DrugPatentWatch Database Preview

Levofloxacin - Generic Drug Details

« Back to Dashboard

What are the generic sources for levofloxacin and what is the scope of levofloxacin patent protection?

Levofloxacin
is the generic ingredient in six branded drugs marketed by Janssen Pharms, Akorn, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Hospira Inc, Sagent Agila Llc, Zydus Pharms Usa Inc, Acs Dobfar Info Sa, Fresenius Kabi Usa, Hikma Farmaceutica, Santen, Apotex Inc, Rising Pharms Inc, Watson Labs Teva, Hi Tech Pharma, Cipla Ltd, Dr Reddys Labs Inc, Glenmark Generics, Hetero Labs Ltd V, Jubilant Generics, Lupin, Macleods Pharms Ltd, Mylan, Orchid Hlthcare, Sandoz, Teva, Torrent Pharms, Watson Labs Inc, and Wockhardt, and is included in forty-one NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for levofloxacin. Sixty-seven suppliers are listed for this compound. There are four tentative approvals for this compound.
Pharmacology for levofloxacin
Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Tentative approvals for LEVOFLOXACIN
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe5MG/MLINJECTABLE; INJECTION
➤ Subscribe➤ Subscribe250MGTABLET; ORAL
➤ Subscribe➤ Subscribe750MGTABLET; ORAL

US Patents and Regulatory Information for levofloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar Info Sa LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 090343-001 Jul 7, 2011 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva LEVOFLOXACIN levofloxacin TABLET;ORAL 076361-003 Jun 20, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz LEVOFLOXACIN levofloxacin TABLET;ORAL 077438-003 Jun 20, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 200674-001 Jun 19, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Emcure Pharms Ltd LEVOFLOXACIN levofloxacin INJECTABLE;INJECTION 202590-002 Jan 24, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 206919-001 Feb 10, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd LEVOFLOXACIN levofloxacin TABLET;ORAL 076890-001 Mar 30, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd LEVOFLOXACIN levofloxacin TABLET;ORAL 076890-003 Mar 30, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Macleods Pharms Ltd LEVOFLOXACIN levofloxacin TABLET;ORAL 200839-002 Mar 22, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Torrent Pharms LEVOFLOXACIN levofloxacin TABLET;ORAL 090722-003 Jun 20, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for levofloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-002 Dec 20, 1996 ➤ Subscribe ➤ Subscribe
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 ➤ Subscribe ➤ Subscribe
Janssen Pharms LEVAQUIN levofloxacin TABLET;ORAL 020634-003 Sep 8, 2000 ➤ Subscribe ➤ Subscribe
Janssen Pharms LEVAQUIN levofloxacin INJECTABLE;INJECTION 020635-001 Dec 20, 1996 ➤ Subscribe ➤ Subscribe
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-005 Dec 20, 1996 ➤ Subscribe ➤ Subscribe
Janssen Pharms LEVAQUIN levofloxacin TABLET;ORAL 020634-001 Dec 20, 1996 ➤ Subscribe ➤ Subscribe
Janssen Pharms LEVAQUIN levofloxacin SOLUTION;ORAL 021721-001 Oct 21, 2004 ➤ Subscribe ➤ Subscribe
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 ➤ Subscribe ➤ Subscribe
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 ➤ Subscribe ➤ Subscribe
Janssen Pharms LEVAQUIN levofloxacin TABLET;ORAL 020634-001 Dec 20, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Citi
Merck
Moodys
QuintilesIMS
McKinsey
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot